Zobrazeno 1 - 10
of 10
pro vyhledávání: '"John Michael Thomas"'
Autor:
Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem
Publikováno v:
Oncotarget
Background: Tumor mutational burden (TMB) is a potential biomarker to predict tumor response to immuno-oncology agents in patients with metastatic non-small cell lung cancer (NSCLC). Materials and Methods: A multi-site cohort study evaluated patients
Autor:
Lisa-Marie Sturla, Ming Tong, Nick Hebda, Jinsong Gao, John-Michael Thomas, Mark Olsen, Suzanne M. de la Monte
Publikováno v:
Heliyon, Vol 2, Iss 12 (2016)
Background: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below 15 months from diagnosis due to GBM’s highly infiltrative nature which precludes complete surgical resection. Patient outcomes could potentially be
Externí odkaz:
https://doaj.org/article/2f58054f2fb14f30b6c7e4398c656dc1
Autor:
Jennifer L, McQuade, Hans, Hammers, Helena, Furberg, Andreas, Engert, Thierry, André, George, Blumenschein, Nizar, Tannir, Ari, Baron, James, Larkin, Anthony, El-Khoueiry, David P, Carbone, John-Michael, Thomas, Delphine, Hennicken, Mary, Coffey, Robert J, Motzer
Publikováno v:
JAMA Oncology. 9:102
ImportanceIncreased survival with immune checkpoint inhibitors has been reported for patients with obesity vs a normal body mass index (BMI). However, the association of obesity with the safety of immune checkpoint inhibitors warrants study.Objective
Autor:
Chiung-Kuei Huang, Yoshifumi Iwagami, Arihiro Aihara, Waihong Chung, Suzanne de la Monte, John-Michael Thomas, Mark Olsen, Rolf Carlson, Tunan Yu, Xiaoqun Dong, Jack Wands
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150336 (2016)
Cholangiocarcinoma (CCA) has a poor prognosis due to widespread intrahepatic spread. Aspartate β-hydroxylase (ASPH) is a transmembrane protein and catalyzes the hydroxylation of aspartyl and asparaginyl residues in calcium binding epidermal growth f
Externí odkaz:
https://doaj.org/article/719d75f29f624c8c8bb27f56595db1cc
Autor:
Florencio Calderon, John Michael Thomas, Michelle Fiander, David D. Stenehjem, Dao Tran, Teresa Zyczynski, Connor Willis, Diana I. Brixner, Beata Korytowsky
Publikováno v:
Oncotarget
// Connor Willis 1 , Michelle Fiander 1 , Dao Tran 2 , Beata Korytowsky 3 , John-Michael Thomas 3 , Florencio Calderon 3 , Teresa M. Zyczynski 3 , Diana Brixner 1 and David D. Stenehjem 1 , 2 1 Department of Pharmacotherapy, University of Utah, Salt
Autor:
Connor Willis, Hillevi Bauer, Trang H. Au, Jyothi Menon, Sudhir Unni, Dao Tran, Zachary Rivers, Wallace Akerley, Matthew B. Schabath, Firas Badin, Ashley Sekhon, Malini Patel, Bing Xia, Beth Gustafson, John L. Villano, John-Michael Thomas, Solomon J. Lubinga, Michael A. Cantrell, Diana Brixner, David Stenehjem
Publikováno v:
Oncotarget. 13:1306-1306
Autor:
Chiung-Kuei Huang, Xiaoqun Dong, Yoshifumi Iwagami, Qiushi Lin, Grace Jang, Jack R. Wands, Miran Kim, Carl E. Wagner, Mark Olsen, Rolf I. Carlson, John Michael Thomas
Publikováno v:
Hepatology. 63:1213-1226
Aspartate β-hydroxylase (ASPH) is an enzyme overexpressed in human hepatocellular carcinoma (HCC) tumors that participates in the malignant transformation process. We determined if ASPH was a therapeutic target by exerting effects on cellular senesc
Autor:
Robert J. Motzer, Hans J. Hammers, Nizar M. Tannir, Delphine Hennicken, David P. Carbone, John-Michael Thomas, Roberto Zoffoli, Ari David Baron, James Larkin, Helena Furberg, Mary Coffey, Daniel Reshef, Thierry André, Jennifer L. McQuade, Andreas Engert, Anthony B. El-Khoueiry, George R. Blumenschein
Publikováno v:
Journal of Clinical Oncology. 38:e15114-e15114
e15114 Background: Associations between obesity and cancer risk, prognosis, and therapeutic outcomes have been extensively researched. However, the impact of BMI on safety in patients receiving immunotherapy has not been well described. Methods: A de
Autor:
Suzanne M. de la Monte, John Michael Thomas, Waihong Chung, Arihiro Aihara, Yoshifumi Iwagami, Tunan Yu, Rolf I. Carlson, Jack R. Wands, Mark Olsen, Chiung-Kuei Huang, Xiaoqun Dong
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 3, p e0150336 (2016)
PLoS ONE, Vol 11, Iss 3, p e0150336 (2016)
Cholangiocarcinoma (CCA) has a poor prognosis due to widespread intrahepatic spread. Aspartate β-hydroxylase (ASPH) is a transmembrane protein and catalyzes the hydroxylation of aspartyl and asparaginyl residues in calcium binding epidermal growth f
Autor:
Ming Tong, Nick Hebda, Lisa-Marie Sturla, Jin-Song Gao, Mark Olsen, John-Michael Thomas, Suzanne M. de la Monte
Publikováno v:
Heliyon
Heliyon, Vol 2, Iss 12 (2016)
Heliyon, Vol 2, Iss 12 (2016)
Background: Despite therapeutic advances, survival with glioblastoma multiforme (GBM) remains below 15 months from diagnosis due to GBM’s highly infiltrative nature which precludes complete surgical resection. Patient outcomes could potentially be